scholarly journals Validation of the Omron M3 Intellisense (HEM-7051-E) Upper Arm Blood Pressure Monitor, for Self-Measurement, according to the European Society of Hypertension International Protocol Revision 2010 in a Stage 3–5 Chronic Kidney Disease Population

2012 ◽  
Vol 35 (2) ◽  
pp. 82-88 ◽  
Author(s):  
Tekin Akpolat ◽  
Emre Erdem ◽  
Türkan Aydogdu
Keyword(s):  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
European Society ◽  
Blood Pressure Monitor ◽  
Pressure Monitor ◽  
Upper Arm ◽  
Chronic Kidney Disease Population

scholarly journals QardioArm Upper Arm Blood Pressure Monitor Against Omron M3 Upper Arm Blood Pressure Monitor in Patients With Chronic Kidney Disease: A Validation Study According to the European Society of Hypertension International Protocol Revision 2010

10.2196/14686 ◽  
2019 ◽  
Vol 21 (12) ◽  
pp. e14686 ◽  
Author(s):  
Victoria Mazoteras-Pardo ◽  
Ricardo Becerro-De-Bengoa-Vallejo ◽  
Marta Elena Losa-Iglesias ◽  
Daniel López-López ◽  
David Rodríguez-Sanz ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Validation Study ◽  
European Society ◽  
Blood Pressure Monitor ◽  
Pressure Monitor ◽  
Upper Arm ◽  
Oscillometric Device ◽  
Validation Criteria

Background Hypertension is considered as a main risk factor for chronic kidney disease development and progression. Thus, the control and evaluation of this disease with new software and devices are especially important in patients who suffer from chronic kidney disease. Objective This study aimed to validate the QardioArm mobile device, which is used for blood pressure (BP) self-measurement in patients who suffer from chronic kidney disease, by following the European Society of Hypertension International Protocol 2 (ESH-IP2) guidelines. Methods A validation study was carried out by following the ESH-IP2 guidelines. A sample of 33 patients with chronic kidney disease self-measured their BP by using the QardioArm and Omron M3 Intellisense devices. Heart rate (HR), diastolic BP, and systolic BP were measured. Results The QardioArm fulfilled the ESH-IP2 validation criteria in patients who suffered from chronic kidney disease. Conclusions Thus, this study is considered as the first validation using a wireless upper arm oscillometric device connected to an app to measure BP and HR meeting the ESH-IP2 requirements in patients who suffer from chronic kidney disease. New validation studies following the ESH-IP2 guidelines should be carried out using different BP devices in patients with specific diseases.

Validation of the Beurer BM 44 upper arm blood pressure monitor for home measurement, according to the European Society of Hypertension International Protocol 2002

2012 ◽  
Vol 17 (6) ◽  
pp. 248-252 ◽  
Author(s):  
Stephan Lüders ◽  
Ralf Krüger ◽  
Claudia Zemmrich ◽  
Klaus Forstner ◽  
Claus-Dieter Sturm ◽  
...  
Keyword(s):  
Blood Pressure ◽  
European Society ◽  
Blood Pressure Monitor ◽  
Pressure Monitor ◽  
Upper Arm

Validation of the Andon KD-5851 upper arm blood pressure monitor, for self-measurement according to the European Society of Hypertension International Protocol revision 2010

2015 ◽  
Vol 20 (4) ◽  
pp. 228-231
Author(s):  
Lili Wu ◽  
Yinghui Jiao ◽  
Chengdong Wang ◽  
Lei Chen ◽  
Dalin Di ◽  
...  
Keyword(s):  
Blood Pressure ◽  
European Society ◽  
Blood Pressure Monitor ◽  
Pressure Monitor ◽  
Upper Arm
Sign in / Sign up

Export Citation Format

Share Document